Literature DB >> 26441302

The burden of behavioral risk factors for cardiovascular disease in Europe. A significant prevention deficit.

Maria Vassilaki1, Manolis Linardakis2, Donna M Polk3, Αnastas Philalithis2.   

Abstract

OBJECTIVE: The study objective was to assess the burden of major cardiovascular disease (CVD) behavioral risk factors (BRFs) (i.e., smoking, excess body weight, physical inactivity, risky alcohol consumption) among individuals in the community with and without CVD history.
METHODS: For the current study, a subset of the data from the Survey of Health, Ageing and Retirement in Europe (SHARE) was analyzed, which were collected from 26,743 individuals aged 50+ years old, during the 1st wave of SHARE in 2004/05 in eleven European countries.
RESULTS: Among those with CVD, there is a statistically significant higher percentage of inactive individuals (81.4% vs. 69.5 among those without CVD), and of individuals with excess body weight (64.3%) or obese (21.6%). Patients with CVD had a lower prevalence of smoking and risky alcohol consumption in most countries, whereas the prevalence of high body weight and physical inactivity was higher in CVD patients compared to individuals without CVD in almost all countries. More than half of the population has at least two BRFs, with a significantly higher prevalence of multiple BRFs among those diagnosed with CVD.
CONCLUSION: Study findings suggest that a significant burden of behavioral risk factors for CVD remains in the population overall but also among patients diagnosed with CVD. Given the significant prevalence of BRFs, the prevention benefits would be immense for all stakeholders involved and negligence would be perilous.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behavioral risk factors; Cardiovascular disease; Prevalence; SHARE study

Mesh:

Year:  2015        PMID: 26441302      PMCID: PMC7147462          DOI: 10.1016/j.ypmed.2015.09.024

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  35 in total

1.  Prevalence of multiple chronic disease risk factors. 2001 National Health Interview Survey.

Authors:  Lawrence J Fine; G Stephane Philogene; Robert Gramling; Elliot J Coups; Sarbajit Sinha
Journal:  Am J Prev Med       Date:  2004-08       Impact factor: 5.043

Review 2.  Stagnant in cardiovascular prevention: alarming trends and persistent socioeconomic obstacles.

Authors:  Tomás Romero; Camila X Romero
Journal:  Rev Esp Cardiol       Date:  2010-11       Impact factor: 4.753

3.  EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.

Authors: 
Journal:  Eur Heart J       Date:  1997-10       Impact factor: 29.983

4.  How to improve cardiovascular diseases prevention in Europe?

Authors:  Z Reiner
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-09       Impact factor: 4.222

5.  Cardiovascular disease in Europe: epidemiological update.

Authors:  Melanie Nichols; Nick Townsend; Peter Scarborough; Mike Rayner
Journal:  Eur Heart J       Date:  2013-09-07       Impact factor: 29.983

Review 6.  Obesity: the 'huge' problem in cardiovascular diseases.

Authors:  M Javed Ashraf; Paramdeep Baweja
Journal:  Mo Med       Date:  2013 Nov-Dec

Review 7.  Barriers to cardiovascular disease risk scoring and primary prevention in Europe.

Authors:  F D R Hobbs; J W Jukema; P M Da Silva; T McCormack; A L Catapano
Journal:  QJM       Date:  2010-08-04

8.  Frequency of physician-directed assistance for smoking cessation in patients receiving cessation medications.

Authors:  Leif I Solberg; Stephen E Asche; Raymond G Boyle; Jackie L Boucher; Nicolaas P Pronk
Journal:  Arch Intern Med       Date:  2005-03-28

9.  Primordial prevention of cardiovascular disease.

Authors:  Matthew W Gillman
Journal:  Circulation       Date:  2015-01-20       Impact factor: 29.690

10.  EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.

Authors:  Kornelia Kotseva; David Wood; Guy De Backer; Dirk De Bacquer; Kalevi Pyörälä; Ulrich Keil
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2009-04
View more
  3 in total

1.  Serum adipocyte-fatty acid binding protein (FABP4) levels in women from Mexico exposed to polycyclic aromatic hydrocarbons (PAHs).

Authors:  Ángeles C Ochoa-Martínez; Tania Ruíz-Vera; Lucia G Pruneda-Álvarez; Ana K González-Palomo; Claudia I Almendarez-Reyna; Francisco J Pérez-Vázquez; Iván N Pérez-Maldonado
Journal:  Environ Sci Pollut Res Int       Date:  2016-10-31       Impact factor: 4.223

2.  Evaluation of epigenetic alterations (mir-126 and mir-155 expression levels) in Mexican children exposed to inorganic arsenic via drinking water.

Authors:  Mónica S Pérez-Vázquez; Ángeles C Ochoa-Martínez; Tania RuÍz-Vera; Yesenia Araiza-Gamboa; Iván N Pérez-Maldonado
Journal:  Environ Sci Pollut Res Int       Date:  2017-10-06       Impact factor: 4.223

3.  Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors.

Authors:  Nuria Perretta-Tejedor; Javier Fernández-Mateos; Luis García-Ortiz; Manuel A Gómez-Marcos; José I Recio-Rodríguez; Cristina Agudo-Conde; Emiliano Rodriguez-Sánchez; Ana I Morales; Francisco J López-Hernández; José M López-Novoa; Rogelio González-Sarmiento; Carlos Martínez-Salgado
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.